Your browser doesn't support javascript.
loading
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
Goyama, S; Schibler, J; Gasilina, A; Shrestha, M; Lin, S; Link, K A; Chen, J; Whitman, S P; Bloomfield, C D; Nicolet, D; Assi, S A; Ptasinska, A; Heidenreich, O; Bonifer, C; Kitamura, T; Nassar, N N; Mulloy, J C.
Affiliation
  • Goyama S; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Schibler J; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Gasilina A; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Shrestha M; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Lin S; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Link KA; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Chen J; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Whitman SP; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Bloomfield CD; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Nicolet D; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Assi SA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Ptasinska A; Alliance for Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Heidenreich O; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Bonifer C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Kitamura T; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Nassar NN; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Mulloy JC; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Leukemia ; 30(3): 728-39, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26449661
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Preleukemia / Leukemia, Myeloid, Acute / Gene Expression Regulation, Leukemic / Oncogene Proteins, Fusion / Protein Tyrosine Phosphatases / Proto-Oncogene Proteins c-cbl / Core Binding Factor Alpha 2 Subunit Type of study: Prognostic_studies Language: En Journal: Leukemia Year: 2016 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Preleukemia / Leukemia, Myeloid, Acute / Gene Expression Regulation, Leukemic / Oncogene Proteins, Fusion / Protein Tyrosine Phosphatases / Proto-Oncogene Proteins c-cbl / Core Binding Factor Alpha 2 Subunit Type of study: Prognostic_studies Language: En Journal: Leukemia Year: 2016 Document type: Article